The National Cancer Vanguard is delighted to announce a unique opportunity for a select group of industry partners to work on projects to improve early diagnosis of cancer. In preparation for the launch of the Early Diagnosis Industry Challenge they are making an open invitation for potential partners to hear more about the call before the formal launch.
The call will launch in late February and close in March 2017. The aim is to engage expertise from outside the NHS to undertake a smaller number of high impact projects which will ultimately lead to a tangible improvement in the earlier diagnosis of cancer in the NHS.
Background to the Early Diagnosis Industry Challenge
Realising improvements in patient outcomes and experience which can be scaled effectively across the NHS is the core aim of the Cancer Vanguard. Early diagnosis is crucial to improving outcomes for cancer patients. In the UK we know there is a need to diagnose cancer earlier in order to achieve survival outcomes comparable to best practice internationally. Engaging the expertise and capability of partners outside the NHS through this challenge process will serve to better realise this aim.
This call follows a similar process in 2016 which engaged successfully with partners in the pharmaceutical industry to support deliverables in medicines optimisation. This resulted in five projects which are on track to deliver significant, scalable benefits for patients and support improved financial sustainability in the NHS.
Please contact the Cancer Vanguard team at CancerVanguard@uclh.nhs.uk if you have further questions or would like to book your place at the information and discussion session on 8 February.